These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
458 related items for PubMed ID: 24399811
21. Skin manifestations of systemic lupus erythematosus refractory to multiple treatment modalities: poor results with mycophenolate mofetil. Pisoni CN, Obermoser G, Cuadrado MJ, Sanchez FJ, Karim Y, Sepp NT, Khamashta MA, Hughes GR. Clin Exp Rheumatol; 2005; 23(3):393-6. PubMed ID: 15971430 [Abstract] [Full Text] [Related]
22. Mycophenolate mofetil treatment in children and adolescents with lupus. Kazyra I, Pilkington C, Marks SD, Tullus K. Arch Dis Child; 2010 Dec; 95(12):1059-61. PubMed ID: 20810399 [Abstract] [Full Text] [Related]
23. Mycophenolate mofetil for the treatment of systemic lupus erythematosus: an open pilot trial. Gaubitz M, Schorat A, Schotte H, Kern P, Domschke W. Lupus; 1999 Dec; 8(9):731-6. PubMed ID: 10602445 [Abstract] [Full Text] [Related]
24. Therapeutic drug monitoring of mycophenolate mofetil and enteric-coated mycophenolate sodium in patients with systemic lupus erythematosus. Djabarouti S, Duffau P, Lazaro E, Chapouly C, Greib C, Viallard JF, Pellegrin JL, Saux MC, Breilh D. Expert Opin Pharmacother; 2010 Apr; 11(5):689-99. PubMed ID: 20210680 [Abstract] [Full Text] [Related]
25. Mycophenolate mofetil in systemic lupus erythematosus: efficacy and tolerability in 86 patients. Pisoni CN, Sanchez FJ, Karim Y, Cuadrado MJ, D'Cruz DP, Abbs IC, Khamasta MA, Hughes GR. J Rheumatol; 2005 Jun; 32(6):1047-52. PubMed ID: 15940766 [Abstract] [Full Text] [Related]
26. Mycophenolate mofetil and systemic lupus erythematosus: an overview. Pisoni CN, Karim Y, Cuadrado MJ. Lupus; 2005 Jun; 14 Suppl 1():s9-11. PubMed ID: 15803925 [Abstract] [Full Text] [Related]
27. The efficacy of low-dose mycophenolate mofetil for treatment of lupus nephritis in Taiwanese patients with systemic lupus erythematosus. Weng MY, Weng CT, Liu MF. Clin Rheumatol; 2010 Jul; 29(7):771-5. PubMed ID: 20195879 [Abstract] [Full Text] [Related]
28. Differential effects of cyclophosphamide and mycophenolate mofetil on cellular and serological parameters in patients with systemic lupus erythematosus. Fassbinder T, Saunders U, Mickholz E, Jung E, Becker H, Schlüter B, Jacobi AM. Arthritis Res Ther; 2015 Apr 03; 17(1):92. PubMed ID: 25890338 [Abstract] [Full Text] [Related]
29. Mycophenolate mofetil treatment of severe renal disease in pediatric onset systemic lupus erythematosus. Buratti S, Szer IS, Spencer CH, Bartosh S, Reiff A. J Rheumatol; 2001 Sep 03; 28(9):2103-8. PubMed ID: 11550982 [Abstract] [Full Text] [Related]
30. Mycophenolic acid exposure and complement fraction C3 influence inosine 5'-monophosphate dehydrogenase activity in systemic lupus erythematosus. Mino Y, Naito T, Shimoyama K, Ogawa N, Kawakami J. Ann Clin Biochem; 2017 Jul 03; 54(4):490-494. PubMed ID: 27538768 [Abstract] [Full Text] [Related]
31. Mycophenolate mofetil in anti-neutrophil cytoplasm antibodies-associated systemic vasculitis. Koukoulaki M, Jayne DR. Nephron Clin Pract; 2006 Jul 03; 102(3-4):c100-7. PubMed ID: 16286784 [Abstract] [Full Text] [Related]
32. Mycophenolate mofetil for the treatment of juvenile onset SLE: a multicenter study. Falcini F, Capannini S, Martini G, La Torre F, Vitale A, Mangiantini F, Nacci F, Cerinic MM, Cimaz R, Zulian F. Lupus; 2009 Feb 03; 18(2):139-43. PubMed ID: 19151115 [Abstract] [Full Text] [Related]
33. Diffuse large B-cell lymphoma of the central nervous system in mycophenolate mofetil-treated patients with systemic lupus erythematosus. Tsang HH, Trendell-Smith NJ, Wu AK, Mok MY. Lupus; 2010 Mar 03; 19(3):330-3. PubMed ID: 19897521 [Abstract] [Full Text] [Related]
34. Glucocorticoid-induced diabetes mellitus in patients with systemic lupus erythematosus treated with high-dose glucocorticoid therapy. Ha Y, Lee KH, Jung S, Lee SW, Lee SK, Park YB. Lupus; 2011 Oct 03; 20(10):1027-34. PubMed ID: 21659423 [Abstract] [Full Text] [Related]
35. Mycophenolate mofetil as a treatment for autoimmune haemolytic anaemia in patients with systemic lupus erythematosus and antiphospholipid syndrome. Alba P, Karim MY, Hunt BJ. Lupus; 2003 Oct 03; 12(8):633-5. PubMed ID: 12945724 [Abstract] [Full Text] [Related]
36. Randomized trial of enteric-coated mycophenolate sodium versus mycophenolate mofetil in multi-system autoimmune disease. Jones RB, Walsh M, Chaudhry AN, Smith KG, Jayne DR. Clin Kidney J; 2014 Dec 03; 7(6):562-8. PubMed ID: 25859373 [Abstract] [Full Text] [Related]
37. Mycophenolate mofetil but not atorvastatin attenuates atherosclerosis in lupus-prone LDLr(-/-) mice. van Leuven SI, Mendez-Fernandez YV, Wilhelm AJ, Wade NS, Gabriel CL, Kastelein JJ, Stroes ES, Tak PP, Major AS. Ann Rheum Dis; 2012 Mar 03; 71(3):408-14. PubMed ID: 21953346 [Abstract] [Full Text] [Related]
38. Mycophenolate mofetil for systemic lupus erythematosus refractory to other immunosuppressive agents. Karim MY, Alba P, Cuadrado MJ, Abbs IC, D'Cruz DP, Khamashta MA, Hughes GR. Rheumatology (Oxford); 2002 Aug 03; 41(8):876-82. PubMed ID: 12154204 [Abstract] [Full Text] [Related]
39. The effects of cyclophosphamide and mycophenolate on end-stage renal disease and death of lupus nephritis. Koo HS, Kim YC, Lee SW, Kim DK, Oh KH, Joo KW, Kim YS, Ahn C, Han JS, Kim S, Chin HJ. Lupus; 2011 Nov 03; 20(13):1442-9. PubMed ID: 21951944 [Abstract] [Full Text] [Related]
40. Mycophenolate mofetil is a highly effective and safe immunosuppressive agent for the treatment of uveitis : a retrospective analysis of 106 patients. Siepmann K, Huber M, Stübiger N, Deuter C, Zierhut M. Graefes Arch Clin Exp Ophthalmol; 2006 Jul 03; 244(7):788-94. PubMed ID: 16163494 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]